Chip Shortage Hinders AI's Cancer Cure Potential, Says Arm CEO

The development of AI-driven cancer cures is being hampered by a global shortage of advanced computer chips, according to Rene Haas, CEO of Arm Holdings, a leading chip designer.

Haas expressed optimism that artificial intelligence will ultimately find solutions to cancer within our lifetime. However, he highlighted that complex tasks, such as modeling the impact of DNA markers on cancer, are currently limited by the availability of high-performance computing power. This scarcity of essential chips is slowing down the pace of research and development in this critical area of health science.